ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹-688 Cr | ₹-893 Cr | ₹-751 Cr | ₹-541 Cr | ₹-289 Cr |
What is the latest Total Non-Current Liabilities ratio of ALKEM LABORATORIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹-688 Cr |
Mar2022 | ₹-893 Cr |
Mar2021 | ₹-751 Cr |
Mar2020 | ₹-541 Cr |
Mar2019 | ₹-289 Cr |
How is Total Non-Current Liabilities of ALKEM LABORATORIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹-688 Cr | Negative | |
Mar2022 | ₹-893 Cr | Negative | |
Mar2021 | ₹-751 Cr | Negative | |
Mar2020 | ₹-541 Cr | Negative | |
Mar2019 | ₹-289 Cr | - |
Compare Total Non-Current Liabilities of peers of ALKEM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALKEM LABORATORIES | ₹58,621.9 Cr | 3.3% | 2.3% | 42% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics |
ALKEM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALKEM LABORATORIES | 3.3% |
2.3% |
42% |
SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses